STOCK TITAN

Aardvark Therapeutics: Griffin may be deemed 4.5% owner

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

For Aardvark Therapeutics, Inc. (AARD) common stock, Citadel-affiliated entities and Kenneth Griffin report beneficial ownership positions. Kenneth Griffin, President and Chief Executive Officer of Citadel GP LLC, may be deemed to own 986,077 shares, or 4.5%. Citadel Advisors LLC, Citadel Advisors Holdings LP and Citadel GP LLC may each be deemed to own 941,677 shares (4.3%); Citadel Securities LLC, 11,049 shares (0.1%); and Citadel Securities Group LP and Citadel Securities GP LLC, 44,400 shares each (0.2%).

Kenneth Griffin beneficial ownership 986,077 shares; 4.5% May be deemed beneficially owned by Kenneth Griffin, with shared voting and dispositive power.
Citadel Advisors-affiliated beneficial ownership 941,677 shares; 4.3% Each of Citadel Advisors LLC, Citadel Advisors Holdings LP and Citadel GP LLC may be deemed to own this amount.
Citadel Securities LLC beneficial ownership 11,049 shares; 0.1% May be deemed beneficially owned by Citadel Securities LLC.
Citadel Securities Group-affiliated beneficial ownership 44,400 shares; 0.2% Each of Citadel Securities Group LP and Citadel Securities GP LLC may be deemed to own this amount.
beneficially own technical
"may be deemed to beneficially own 986,077 Shares"
Beneficially own means having the economic rights and risks of a security—such as the right to receive dividends, sell the shares, or profit from price changes—whether or not your name appears on the official share register. Think of it like renting a car: you use it and reap the benefits even if the title lists someone else. Investors care because beneficial ownership determines who truly controls value, must be disclosed under securities rules, and can signal potential influence or trading activity that affects a stock’s price.
Shared voting power technical
"Shared voting power 986,077"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
Shared dispositive power technical
"Shared dispositive power 986,077"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many AARD shares does Kenneth Griffin report beneficially owning?

Kenneth Griffin may be deemed to beneficially own 986,077 Aardvark common shares, or 4.5%, with shared voting and shared dispositive power.

What share count was used to calculate AARD ownership percentages?

The reported percentages are based on 21,884,846 shares outstanding as of July 31, 2026, according to Aardvark’s Form 10-Q filed August 11, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





002942100

(CUSIP Number)
09/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: The percentages reported in this Schedule 13G are based upon 21,884,846 Shares outstanding as of July 31, 2026 (according to the issuer's Form 10-Q as filed with the Securities and Exchange Commission on August 11, 2026).


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Citadel Advisors LLC
Signature:/s/ Seth Levy
Name/Title:Seth Levy, Authorized Signatory
Date:11/16/2026
Citadel Advisors Holdings LP
Signature:/s/ Seth Levy
Name/Title:Seth Levy, Authorized Signatory
Date:11/16/2026
Citadel GP LLC
Signature:/s/ Seth Levy
Name/Title:Seth Levy, Authorized Signatory
Date:11/16/2026
Citadel Securities LLC
Signature:/s/ Seth Levy
Name/Title:Seth Levy, Authorized Signatory
Date:11/16/2026
Citadel Securities Group LP
Signature:/s/ Seth Levy
Name/Title:Seth Levy, Authorized Signatory
Date:11/16/2026
Citadel Securities GP LLC
Signature:/s/ Seth Levy
Name/Title:Seth Levy, Authorized Signatory
Date:11/16/2026
Kenneth Griffin
Signature:/s/ Seth Levy
Name/Title:Seth Levy, attorney-in-fact*
Date:11/16/2026

Comments accompanying signature: * Seth Levy is signing on behalf of Kenneth Griffin as attorney-in-fact pursuant to a power of attorney previously filed with the Securities and Exchange Commission, and hereby incorporated by reference herein. The power of attorney was filed as an attachment to a filing by Citadel Advisors LLC on Schedule 13G for Allakos Inc. on October 13, 2023.

Keep reading